Summary

for people ages up to 120 years (full criteria)
at Oakland, California and other locations
study started

Description

Summary

RATIONALE: Collecting and storing samples of tumor tissue and blood from patients to test in the laboratory may help the study of cancer in the future.

PURPOSE: The purpose of this study is to collect and store samples of blood and tumor tissue from patients with osteosarcoma.

Official Title

A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens

Details

OBJECTIVES:

  • To collect biological specimens from patients with osteosarcoma at Children's Oncology Group (COG) institutions.
  • To provide a repository for long-term storage of osteosarcoma-related biological materials.
  • To make these specimens available to qualified researchers to understand the biology of osteosarcoma and correlate these results with the patients' clinical data.

OUTLINE: After the initial submission of blood samples, patients may undergo open or closed biopsy in order to obtain fresh and frozen tissue samples as well as paraffin embedded material. Patients who are enrolled at the time of initial diagnosis but then have a definitive surgery or develop recurrent disease may submit additional samples (paraffin block, frozen and fresh tumor tissue, or slides together with blood samples). Autopsy tumor samples may also be submitted.

Keywords

Sarcoma osteosarcoma

Eligibility

For people ages up to 120 years

DISEASE CHARACTERISTICS:

  • All osteosarcoma patients seen at COG institutions are eligible, including the following:
  • Newly diagnosed patients
  • Patients with recurrent disease who were not enrolled at the time of diagnosis
  • The following specimens from the initial biopsy (and/or definitive surgery if an up-front resection is performed) are required:
  • Paraffin embedded block OR 30 unstained slides
  • Pretreatment blood consisting of 5 mL serum, 10 mL plasma, and 10 mL heparinized whole blood
  • Fresh and frozen tumor specimens

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Patients are not required to enter a therapeutic study to enroll on this study

Locations

  • Children's Hospital and Research Center Oakland
    Oakland, California, 94609, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California, 94115, United States
  • Children's Hospital Central California
    Madera, California, 93638-8762, United States
  • Lucile Packard Children's Hospital at Stanford University Medical Center
    Palo Alto, California, 95798, United States
  • Kaiser Permanente Medical Center - Oakland
    Sacramento, California, 95661, United States
  • Childrens Hospital Los Angeles
    Los Angeles, California, 90027, United States
  • Southern California Permanente Medical Group
    Los Angeles, California, 90027, United States
  • Mattel Children's Hospital at UCLA
    Los Angeles, California, 90095-1752, United States
  • Jonathan Jaques Children's Cancer Center at Miller Children's Hospital
    Long Beach, California, 90801, United States
  • Children's Hospital of Orange County
    Orange, California, 92868, United States
  • Loma Linda University Cancer Institute at Loma Linda University Medical Center
    Loma Linda, California, 92354, United States
  • CCOP - Nevada Cancer Research Foundation
    Las Vegas, Nevada, 89109-2306, United States

Details

Status
in progress, not accepting new patients
Start Date
Sponsor
Children's Oncology Group
ID
NCT00899275
Study Type
Observational
Last Updated
December 11, 2017